Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer

The response of human epidermal growth factor receptor2 (HER2)- positive breast cancer (BC) patients to anti-HER2 targeted therapy is significant. However, the response is not uniform and a proportion of HER2-positive patients do not respond. This study aims to identify predictors of response in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Ayaka, Miligy, Islam M., Shiino, Sho, Toss, Michael S., Eldib, Karim, Kurozumi, Sasagu, Quinn, Cecily M., Badr, Nahla, Murray, Ciara, Provenzano, Elena, Callagy, Grace, Martyn, Cian, Millican-Slater, Rebecca, Purdie, Colin, Purnell, Dave, Pinder, Sarah E., Oyama, Tetsunari, Shaaban, Abeer M., Ellis, Ian, Lee, Andrew H. S., Rakha, Emad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216906/
https://www.ncbi.nlm.nih.gov/pubmed/33526875
http://dx.doi.org/10.1038/s41379-021-00738-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216906/
https://www.ncbi.nlm.nih.gov/pubmed/33526875
http://dx.doi.org/10.1038/s41379-021-00738-5

Ejemplares similares